Literature DB >> 2643050

Successful treatment of an acquired von Willebrand factor antibody by extracorporeal immunoadsorption.

J Uehlinger, E Rose, L M Aledort, R Lemer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2643050     DOI： 10.1056/NEJM198901263200418

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Current management of von Willebrand's disease.

Authors:  G Castaman; F Rodeghiero
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

Review 2.  High-dose intravenous gammaglobulin therapy for acquired von Willebrand disease.

Authors:  P J Van Genderen; D N Papatsonis; J J Michiels; J J Wielenga; J Stibbe; F J Huikeshoven
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

3.  Acquired von Willebrand's disease.

Authors:  B J Hennessy; B White; M Byrne; O P Smith
Journal:  Ir J Med Sci       Date:  1998 Apr-Jun       Impact factor: 1.568
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.